Effect of prenatal glucocorticoids on pulmonary vascular muscularisation in nitrofen-induced congenital diaphragmatic hernia
- PMID: 9473105
- DOI: 10.1016/s0022-3468(98)90366-9
Effect of prenatal glucocorticoids on pulmonary vascular muscularisation in nitrofen-induced congenital diaphragmatic hernia
Abstract
Background/purpose: Pulmonary hypertension (PH) contributes significantly to the mortality of congenital diaphragmatic hernia (CDH). Pulmonary vascular changes in CDH include a reduced vascular bed with increased arterial medial wall thickness and peripheral extension of muscle into intraacinar vessels. Antenatal steroids improve biochemical immaturity, lung compliance, and morphology in experimental CDH animals. The aim of this study was to examine the effects of prenatal glucocorticoid therapy on pulmonary artery muscularisation in CDH rats.
Methods: CDH was induced in fetal rats by the maternal administration of 100 mg of nitrofen by gavage on day 9.5 of gestation (term, day 22). Control animals received olive oil (OO). Dexamethasone (Dex, 0.25 mg/kg) or normal saline (NS) was given by intraperitoneal injection on days 18.5 and 19.5, and fetuses were delivered by caesarean section on day 21.5. Lung sections from five fetuses in each of four experimental groups were studied by a blinded investigator- OO-NS controls, CDH-NS, CDH-Dex, and non-CDH-NS. The external diameter (ED), medial wall thickness (MT), percent of medial wall thickness, and wall structure were evaluated from preacinar arteries accompanying conducting airways, and the intraacinar arterioles associated with the respiratory bronchi and saccules.
Results: In the preacinar arteries, CDH-NS animals had a significantly increased MT percentage compared with OO-NS controls (21.2+/-8.8 v 17.8+/-10.3, P = .0001). CDH-Dex rats had a lower MT percentage than CDH-NS rats (15.5+/-6.7 v 21.2+/-8.8, P = .0001). In the intraacinar region, CDH-Dex fetuses had a reduced percentage of muscularised intraacinar blood vessels compared with CDH-NS and OO-NS controls (10% v 24% and 28%, respectively, P = .01). Dexamethasone-treated CDH pups also displayed a significantly lower MT percentage of the intraacinar arteries compared with CDH-NS and OO-NS animals (15.7+/-13 v 23.4+/-9 and 25.4+/-12, P = .003).
Conclusions: Medial hypertrophy is present in the preacinar but not the intraacinar blood vessels of CDH rats before birth. Dexamethasone inhibits medial hypertrophy and reduces the number of muscularised intraacinar vessels. Antenatal glucocorticoids may reduce the risk of PH developing in human newborns with antenatally diagnosed CDH.
Similar articles
-
Antenatal glucocorticoid therapy suppresses angiotensin-converting enzyme activity in rats with nitrofen-induced congenital diaphragmatic hernia.J Pediatr Surg. 1998 Feb;33(2):286-91. doi: 10.1016/s0022-3468(98)90449-3. J Pediatr Surg. 1998. PMID: 9498404
-
Effect of prenatal tetrandrine therapy on pulmonary vascular structural remodeling in the nitrofen-induced CDH rat model.Chin Med J (Engl). 2000 Sep;113(9):813-6. Chin Med J (Engl). 2000. PMID: 11776077
-
Administration of antenatal glucocorticoids prevents pulmonary artery structural changes in nitrofen-induced congenital diaphragmatic hernia in rats.J Pediatr Surg. 1998 Jul;33(7):1052-6. doi: 10.1016/s0022-3468(98)90530-9. J Pediatr Surg. 1998. PMID: 9694093
-
Recent advances in understanding the pathogenesis of nitrofen-induced congenital diaphragmatic hernia.Pediatr Pulmonol. 2000 May;29(5):394-9. doi: 10.1002/(sici)1099-0496(200005)29:5<394::aid-ppul9>3.0.co;2-2. Pediatr Pulmonol. 2000. PMID: 10790252 Review.
-
Pulmonary hypertension secondary to congenital diaphragmatic hernia: factors and pathways involved in pulmonary vascular remodeling.Pediatr Res. 2019 May;85(6):754-768. doi: 10.1038/s41390-019-0345-4. Epub 2019 Feb 19. Pediatr Res. 2019. PMID: 30780153
Cited by
-
Increased expression of ICAM-1 and VCAM-1 in the lung of nitrofen-induced congenital diaphragmatic hernia in rats.Pediatr Surg Int. 2003 Jul;19(5):365-70. doi: 10.1007/s00383-003-1012-7. Epub 2003 May 21. Pediatr Surg Int. 2003. PMID: 12759764
-
Congenital diaphragmatic hernias: from genes to mechanisms to therapies.Dis Model Mech. 2017 Aug 1;10(8):955-970. doi: 10.1242/dmm.028365. Dis Model Mech. 2017. PMID: 28768736 Free PMC article. Review.
-
Structure and epitope distribution of heparan sulfate is disrupted in experimental lung hypoplasia: a glycobiological epigenetic cause for malformation?BMC Dev Biol. 2011 Jun 14;11:38. doi: 10.1186/1471-213X-11-38. BMC Dev Biol. 2011. PMID: 21672206 Free PMC article.
-
Therapeutic potential of mesenchymal stem cell transplantation in a nitrofen-induced congenital diaphragmatic hernia rat model.Pediatr Surg Int. 2014 Sep;30(9):907-14. doi: 10.1007/s00383-014-3576-9. Epub 2014 Aug 5. Pediatr Surg Int. 2014. PMID: 25092488
-
ANG-1 TIE-2 and BMPR signalling defects are not seen in the nitrofen model of pulmonary hypertension and congenital diaphragmatic hernia.PLoS One. 2012;7(4):e35364. doi: 10.1371/journal.pone.0035364. Epub 2012 Apr 23. PLoS One. 2012. PMID: 22539968 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous